These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38677091)

  • 21. The role of a ceRNA regulatory network based on lncRNA MALAT1 site in cancer progression.
    Su K; Wang N; Shao Q; Liu H; Zhao B; Ma S
    Biomed Pharmacother; 2021 May; 137():111389. PubMed ID: 33601150
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-derived lncRNAs: Behind-the-scenes mediators that modulate the immune system and play a role in cancer pathogenesis.
    Al-Hawary SIS; Saleh RO; Taher SG; Ahmed SM; Hjazi A; Yumashev A; Ghildiyal P; Qasim MT; Alawadi A; Ihsan A
    Pathol Res Pract; 2024 Feb; 254():155123. PubMed ID: 38277740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primate-specific oestrogen-responsive long non-coding RNAs regulate proliferation and viability of human breast cancer cells.
    Lin CY; Kleinbrink EL; Dachet F; Cai J; Ju D; Goldstone A; Wood EJ; Liu K; Jia H; Goustin AS; Kosir MA; Thepsuwan P; Lipovich L
    Open Biol; 2016 Dec; 6(12):. PubMed ID: 28003470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of long noncoding RNAs in colorectal cancer metastasis.
    Li H; Ma SQ; Huang J; Chen XP; Zhou HH
    Oncotarget; 2017 Jun; 8(24):39859-39876. PubMed ID: 28418892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
    Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
    Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNAs involved in different steps of cancer metastasis.
    Suman P; Chhichholiya Y; Kaur P; Ghosh S; Munshi A
    Clin Transl Oncol; 2022 Jun; 24(6):997-1013. PubMed ID: 35119654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple function of lncRNA MALAT1 in cancer occurrence and progression.
    Malakoti F; Targhazeh N; Karimzadeh H; Mohammadi E; Asadi M; Asemi Z; Alemi F
    Chem Biol Drug Des; 2023 May; 101(5):1113-1137. PubMed ID: 34918470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanomaterials-Based Targeting of Long Non-Coding RNAs in Cancer: A Cutting-Edge Review of Current Trends.
    Davodabadi F; Farasati Far B; Sargazi S; Fatemeh Sajjadi S; Fathi-Karkan S; Mirinejad S; Ghotekar S; Sargazi S; Rahman MM
    ChemMedChem; 2024 Apr; 19(8):e202300528. PubMed ID: 38267373
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy.
    Yang K; Xiao Y; Zhong L; Zhang W; Wang P; Ren Y; Shi L
    Cancer Gene Ther; 2023 Nov; 30(11):1456-1470. PubMed ID: 37679529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YAP1-induced MALAT1 promotes epithelial-mesenchymal transition and angiogenesis by sponging miR-126-5p in colorectal cancer.
    Sun Z; Ou C; Liu J; Chen C; Zhou Q; Yang S; Li G; Wang G; Song J; Li Z; Zhang Z; Yuan W; Li X
    Oncogene; 2019 Apr; 38(14):2627-2644. PubMed ID: 30531836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiogenesis regulation by microRNAs and long non-coding RNAs in human breast cancer.
    Chong ZX; Yeap SK; Ho WY
    Pathol Res Pract; 2021 Mar; 219():153326. PubMed ID: 33601152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Portraying breast cancers with long noncoding RNAs.
    Van Grembergen O; Bizet M; de Bony EJ; Calonne E; Putmans P; Brohée S; Olsen C; Guo M; Bontempi G; Sotiriou C; Defrance M; Fuks F
    Sci Adv; 2016 Sep; 2(9):e1600220. PubMed ID: 27617288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting long non-coding RNAs in cancer therapy using CRISPR-Cas9 technology: A novel paradigm for precision oncology.
    Mahato RK; Bhattacharya S; Khullar N; Sidhu IS; Reddy PH; Bhatti GK; Bhatti JS
    J Biotechnol; 2024 Jan; 379():98-119. PubMed ID: 38065367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting long non-coding RNAs in cancers: progress and prospects.
    Li CH; Chen Y
    Int J Biochem Cell Biol; 2013 Aug; 45(8):1895-910. PubMed ID: 23748105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Research Progress on Long Non-Coding RNA and Radiotherapy.
    Yao Z; Zhang Y; Xu D; Zhou X; Peng P; Pan Z; Xiao N; Yao J; Li Z
    Med Sci Monit; 2019 Aug; 25():5757-5770. PubMed ID: 31375656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
    He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
    Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNAs: regulation, function and cancer.
    Rafiee A; Riazi-Rad F; Havaskary M; Nuri F
    Biotechnol Genet Eng Rev; 2018 Oct; 34(2):153-180. PubMed ID: 30071765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer.
    Almalki WH
    Pathol Res Pract; 2023 Nov; 251():154852. PubMed ID: 37837857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-Coding RNAs (lncRNAs) in Response and Resistance to Cancer Immunosurveillance and Immunotherapy.
    Eptaminitaki GC; Wolff N; Stellas D; Sifakis K; Baritaki S
    Cells; 2021 Nov; 10(12):. PubMed ID: 34943820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers.
    Li Z; Yu X; Shen J
    Tumour Biol; 2016 May; 37(5):5657-61. PubMed ID: 26753962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.